Clinical trial

Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based…

NCT00165438 · Dana-Farber Cancer Institute, Other · Completed

Key facts

NCT number NCT00165438
Title Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy
Official title A Prospective Study of Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy With or Without Mediastinal Irradiation
Lead sponsor Dana-Farber Cancer Institute, Other
Collaborators Brigham and Women's Hospital
Status Completed
Study type Observational
Conditions Hodgkin's Disease
Intervention type Procedure
Interventions Pulmonary Function Tests, CAT Scan
Enrollment 60
Start date Oct 1, 2001
Primary completion Nov 1, 2005
Completion Jan 1, 2010
First posted Sep 14, 2005
Last update posted Dec 20, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies